AM095 (free acid) - CAS# 1228690-36-5 Y255283 Drugs in development for Parkinson's

Drugs in development for Parkinson's disease

β-secretase 1 inhibitory activity and AMP-activated protein kinase activation of Callyspongia samarensis extracts

a significant reduction in thrombus weight is observed 24 h later at PAI-039 doses of 3

Smiles: COC1C=CC(=CC=1)S(=O)(=O)NC1=CC=CC=C1CN(C)C/C=C/C1C=CC(Cl)=CC=1

AM095 (free acid) - CAS# 1228690-36-5 Y255283 Drugs in development for Parkinson'sAM095 is a potent LPA1 receptor antagonist because it inhibited GTPS binding to Chinese hamster ovary (CHO) cell membranes overexpressing recombinant human or mouse LPA1 with IC50 values of 0. 98 and 0. 73 M, respectively, and exhibited no LPA1 agonism. Lysophosphatidic acid (LPA) is a bioactive phospholipid that signals through a family of at least six G protein coupled receptors designated LPA1 6. LPA type 1 receptor (LPA1) exhibits widespread